Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases

References

• Gorick CM, Breza VR, Nowak KM, et al. Applications of focused ultrasound-mediated blood-brain barrier opening. Adv Drug Deliv Rev. 2022;191:114583. doi:10.1016/j.addr.2022.114583
   PubMed Web of Science ®Google Scholar
• Wang J, Li Z, Pan M, et al. Ultrasound-mediated blood–brain barrier opening: an effective drug delivery system for theranostics of brain diseases. Adv Drug Deliv Rev. 2022;190:114539.
   PubMed Web of Science ®Google Scholar
• Meng Y, Goubran M, Rabin JS, et al. Blood–brain barrier opening of the default mode network in Alzheimer’s disease with magnetic resonance-guided focused ultrasound. Brain. 2023;146(3):865–872.
   PubMed Web of Science ®Google Scholar
• Lei S, Li J, Yu J, et al. Porphyromonas gingivalis bacteremia increases the permeability of the blood-brain barrier via the Mfsd2a/Caveolin-1 mediated transcytosis pathway. Int J Oral Sci. 2023;15(1):3.
   PubMed Web of Science ®Google Scholar
• Anwar MM, Özkan E, Shomalizadeh N, et al. Assessing the role of primary healthy microglia and gap junction blocker in hindering Alzheimer’s disease neuroinflammatory type: early approaches for therapeutic intervention. Front Neurosci. 2023;16:546.
   Web of Science ®Google Scholar
• Gernert M, Feja M. Bypassing the blood–brain barrier: direct intracranial drug delivery in epilepsies. Pharmaceutics. 2020;12(12):1134.
   PubMed Web of Science ®Google Scholar
• Kang JH, Ko YT. Intraosseous administration into the skull: potential blood–brain barrier bypassing route for brain drug delivery. Bioeng Translational Med. 2022;e10424.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hong H, Xue J, et al. Near-infrared radiation-assisted drug delivery nanoplatform to realize blood–brain barrier crossing and protection for parkinsonian therapy. ACS Appl Mater Interfaces. 2021;13(31):37746–37760.
   PubMed Web of Science ®Google Scholar
• Pena ES, Graham-Gurysh EG, Bachelder EM, Ainslie KM. Design of biopolymer-based interstitial therapies for the treatment of glioblastoma. Int J Mol Sci. 2021;22(23):13160.
   PubMed Web of Science ®Google Scholar
• Reshma S, Megha KB, Amir S, Rukhiya S, Mohanan PV. Blood brain barrier-on-A-chip to model neurological diseases. J Drug Deliv Sci Technol. 2023;80:104174.
   Web of Science ®Google Scholar
• Wei F, Wang Q, Liu H, et al. High Efficacy Combined Microneedles Array with Methotrexate Nanocrystals for Effective Anti-Rheumatoid Arthritis. Int J Nanomedicine. 2022;17:2397–2412.
   PubMed Web of Science ®Google Scholar
• Wu X, Huang D, Xu Y, Chen G, Zhao Y. Microfluidic templated stem cell spheroid microneedles for diabetic wound treatment. Adv Mater. 2014;1:2301064.
   Google Scholar
• Chen H, Fan L, Peng N, et al. Galunisertib-loaded gelatin methacryloyl hydrogel microneedle patch for cardiac repair after myocardial infarction. ACS Appl Mater Interfaces. 2022;14(36):40491–40500.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ye F, Zhang T, et al. Structural basis of ketamine action on human NMDA receptors. Nature. 2021;596(7871):301–305.
   PubMed Web of Science ®Google Scholar
• Courtenay AJ, McAlister E, McCrudden MTC, et al. Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery. J Controlled Release. 2020;322:177–186.
   PubMed Web of Science ®Google Scholar
• Pervaiz F, Saba A, Yasin H, et al. Fabrication of solid lipid nanoparticles-based patches of paroxetine and their ex-vivo permeation behaviour. Artif Cells Nanomed Biotechnol. 2023;51(1):108–119.
   PubMed Web of Science ®Google Scholar
• Kowalska M, Nowaczyk J, Fijałkowski Ł, Nowaczyk A. Paroxetine—overview of the molecular mechanisms of action. Int J Mol Sci. 2021;22(4):1662.
   PubMed Web of Science ®Google Scholar
• Li F, Wen Y, Zhang Y, et al. Characterisation of 2-HP-beta-cyclodextrin-PLGA nanoparticle complexes for potential use as ocular drug delivery vehicles. Artif Cells Nanomed Biotechnol. 2019;47(1):4097–4108.
   PubMed Web of Science ®Google Scholar
• Men Z, Lu X, He T, Wu M, Su T, Shen T. Microneedle patch-assisted transdermal administration of recombinant hirudin for the treatment of thrombotic diseases. Int J Pharm. 2022;612:121332.
   PubMedGoogle Scholar
• Zhang W, Mehta A, Tong Z, Esser L, Voelcker NH. Development of polymeric nanoparticles for blood–brain barrier transfer—strategies and challenges. Adv Sci. 2021;8(10):2003937.
   Web of Science ®Google Scholar
• López-Cabeza R, Kah M, Grillo R, Bílková Z, Hofman J. Is centrifugal ultrafiltration a robust method for determining encapsulation efficiency of pesticide nanoformulations? Nanoscale. 2021;13(10):5410–5418.
   PubMed Web of Science ®Google Scholar
• Ghazi RF, Al-Mayahy MH. Levothyroxine sodium loaded dissolving microneedle arrays for transdermal delivery. ADMET and DMPK. 2022;10(3):213–230.
   Google Scholar
• Li H, Yao J, Guo Y, et al. Preparation of conotoxin-encapsulated chitosan nanoparticles and evaluation of their skin permeability. AAPS PharmSciTech. 2023;24(1):53.
   PubMed Web of Science ®Google Scholar
• Hawkins S, Dasgupta BR, Ananthapadmanabhan KP. Role of pH in skin cleansing. Int J Cosmet Sci. 2021;43(4):474–483.
   PubMed Web of Science ®Google Scholar
• Min HS, Kim Y, Nam J, et al. Shape of dissolving microneedles determines skin penetration ability and efficacy of drug delivery. Biomaterials Adv. 2023;145:213248.
   PubMedGoogle Scholar
• Han X, Ma T, Wang Q, et al. The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway. Front Pharmacol. 2023;13.
   Web of Science ®Google Scholar
• Kucharz K, Kristensen K, Johnsen KB, et al. Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles. Nat Commun. 2021;12(1):4121.
   PubMed Web of Science ®Google Scholar
• Xiang H, Xu S, Zhang W, Li Y, Zhou Y, Miao X. Skin permeation of curcumin nanocrystals: effect of particle size, delivery vehicles, and permeation enhancer. Colloids Surf B Biointerfaces. 2023;224:113203.
   PubMed Web of Science ®Google Scholar
• Chi Y, Huang Y, Kang Y, et al. The effects of molecular weight of hyaluronic acid on transdermal delivery efficiencies of dissolving microneedles. Eur J Pharmaceutical Sci. 2022;168:106075.
   PubMed Web of Science ®Google Scholar
• Bognanni N, Viale M, La Piana L, et al. Hyaluronan-cyclodextrin conjugates as doxorubicin delivery systems. Pharmaceutics. 2023;15(2):374.
   PubMed Web of Science ®Google Scholar
• Kang MS, Kwon M, Lee SH, et al. 3D printing of skin equivalents with hair follicle structures and epidermal-papillary-dermal layers using gelatin/hyaluronic acid hydrogels. Chemistry Asian J. 2022;17(18):e202200620.
   PubMed Web of Science ®Google Scholar
• Wang H, Mu X, Yang J, Liang Y, Zhang X-D, Ming D. Brain imaging with near-infrared fluorophores. Coord Chem Rev. 2019;380:550–571.
   Web of Science ®Google Scholar
• Malong L, Napoli I, Casal G, et al. Characterization of the structure and control of the blood-nerve barrier identifies avenues for therapeutic delivery. Dev Cell. 2023;58(3):174–191.e178.
   PubMed Web of Science ®Google Scholar
• Semyachkina-Glushkovskaya O, Bragin D, Bragina O, et al. Low-level laser treatment induces the blood-brain barrier opening and the brain drainage system activation: delivery of liposomes into mouse glioblastoma. Pharmaceutics. 2023;15(2):567.
   PubMed Web of Science ®Google Scholar
• Lin J-F, Liu Y-S, Huang Y-C, et al. Borneol and Tetrandrine Modulate the Blood–Brain Barrier and Blood–Tumor Barrier to Improve the Therapeutic Efficacy of 5-Fluorouracil in Brain Metastasis. Integr Cancer Ther. 2022;21:15347354221077682.
   Web of Science ®Google Scholar
• Sahu KJ, Mishra KA. Tools in the Design of Therapeutic Drugs for CNS Disorders: an up-to-date Review. Curr Mol Pharmacol. 2018;11(4):270–278.
   PubMed Web of Science ®Google Scholar
• Liu T, Xie Q, Dong Z, Peng Q. Nanoparticles-based delivery system and its potentials in treating central nervous system disorders. Nanotechnology. 2022;33(45):452001.
   Web of Science ®Google Scholar
• Bellefroid C, Lechanteur A, Evrard B, Mottet D, Debacq-Chainiaux F, Piel G. In vitro skin penetration enhancement techniques: a combined approach of ethosomes and microneedles. Int J Pharm. 2019;572:118793.
   PubMedGoogle Scholar
• Rawat M, Singh D, Saraf S, Saraf S. Nanocarriers: promising vehicle for bioactive drugs. Biol Pharm Bull. 2006;29(9):1790–1798.
   PubMed Web of Science ®Google Scholar
• Meng Q, Meng H, Pan Y, et al. Influence of nanoparticle size on blood–brain barrier penetration and the accumulation of anti-seizure medicines in the brain. J Materials Chem B. 2022;10(2):271–281.
   PubMed Web of Science ®Google Scholar
• Ruan S, Zhang Y, Feng N. Microneedle-mediated transdermal nanodelivery systems: a review. Biomaterials Sci. 2021;9(24):8065–8089.
   PubMed Web of Science ®Google Scholar
• Prabahar K, Udhumansha U, Elsherbiny N, Qushawy M. Microneedle mediated transdermal delivery of β-sitosterol loaded nanostructured lipid nanoparticles for androgenic alopecia. Drug Deliv. 2022;29(1):3022–3034.
   PubMed Web of Science ®Google Scholar